Clinical Trial Update: Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating low-dose oral interferon alpha in idiopathic pulmonary fibrosis completed; results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Interferon-alpha (interferon alpha)

Snippet

Sponsor: Texas Tech University Health Sciences Center | Conditions: Respiratory Tract Diseases, Lung Diseases | Phase 2 | Status: COMPLETED | Results posted: 2011-09-29